Ad is loading...
RLAY
Price
$4.64
Change
-$0.00 (-0.00%)
Updated
Nov 21 closing price
90 days until earnings call
TERN
Price
$5.71
Change
-$0.00 (-0.00%)
Updated
Nov 21 closing price
130 days until earnings call
Ad is loading...

RLAY vs TERN

Header iconRLAY vs TERN Comparison
Open Charts RLAY vs TERNBanner chart's image
Relay Therapeutics
Price$4.64
Change-$0.00 (-0.00%)
Volume$1.77M
CapitalizationN/A
Terns Pharmaceuticals
Price$5.71
Change-$0.00 (-0.00%)
Volume$1.58M
CapitalizationN/A
RLAY vs TERN Comparison Chart
Loading...
RLAY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
TERN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
RLAY vs. TERN commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RLAY is a Buy and TERN is a StrongSell.

COMPARISON
Comparison
Nov 23, 2024
Stock price -- (RLAY: $4.64 vs. TERN: $5.71)
Brand notoriety: RLAY and TERN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RLAY: 115% vs. TERN: 83%
Market capitalization -- RLAY: $776.66M vs. TERN: $485M
RLAY [@Biotechnology] is valued at $776.66M. TERN’s [@Biotechnology] market capitalization is $485M. The market cap for tickers in the [@Biotechnology] industry ranges from $463.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RLAY’s FA Score shows that 1 FA rating(s) are green whileTERN’s FA Score has 0 green FA rating(s).

  • RLAY’s FA Score: 1 green, 4 red.
  • TERN’s FA Score: 0 green, 5 red.
According to our system of comparison, RLAY is a better buy in the long-term than TERN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RLAY’s TA Score shows that 4 TA indicator(s) are bullish while TERN’s TA Score has 4 bullish TA indicator(s).

  • RLAY’s TA Score: 4 bullish, 4 bearish.
  • TERN’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both RLAY and TERN are a good buy in the short-term.

Price Growth

RLAY (@Biotechnology) experienced а -17.14% price change this week, while TERN (@Biotechnology) price change was -12.82% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.14%. For the same industry, the average monthly price growth was -4.97%, and the average quarterly price growth was +4.04%.

Reported Earning Dates

RLAY is expected to report earnings on Feb 20, 2025.

TERN is expected to report earnings on Apr 01, 2025.

Industries' Descriptions

@Biotechnology (+2.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RLAY($795M) has a higher market cap than TERN($492M). TERN YTD gains are higher at: -12.018 vs. RLAY (-57.856). TERN has higher annual earnings (EBITDA): -99.08M vs. RLAY (-389.45M). RLAY has more cash in the bank: 840M vs. TERN (373M). TERN has less debt than RLAY: TERN (1.31M) vs RLAY (49.8M). RLAY has higher revenues than TERN: RLAY (10M) vs TERN (0).
RLAYTERNRLAY / TERN
Capitalization795M492M162%
EBITDA-389.45M-99.08M393%
Gain YTD-57.856-12.018481%
P/E RatioN/AN/A-
Revenue10M0-
Total Cash840M373M225%
Total Debt49.8M1.31M3,816%
TECHNICAL ANALYSIS
Technical Analysis
RLAYTERN
RSI
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
74%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
75%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 17 days ago
81%
Bullish Trend 12 days ago
82%
Declines
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
82%
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
86%
View a ticker or compare two or three
Ad is loading...
RLAY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
TERN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FRSLX27.580.53
+1.96%
Nuveen Mid Cap Growth Opps A
IRSSX14.800.24
+1.65%
Voya Russell Small Cap Index Port S
LGLSX47.880.50
+1.06%
Lord Abbett Growth Leaders R4
AEYGX34.000.23
+0.68%
American Century Equity Growth R5
CSQCX10.22N/A
N/A
Calvert Global Small-Cap Equity C

RLAY and

Correlation & Price change

A.I.dvisor indicates that over the last year, RLAY has been loosely correlated with XNCR. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if RLAY jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RLAY
1D Price
Change %
RLAY100%
-0.43%
XNCR - RLAY
54%
Loosely correlated
+1.60%
BCYC - RLAY
46%
Loosely correlated
-0.49%
ABOS - RLAY
45%
Loosely correlated
-2.53%
TVTX - RLAY
45%
Loosely correlated
+2.24%
PGEN - RLAY
44%
Loosely correlated
+7.91%
More

TERN and

Correlation & Price change

A.I.dvisor indicates that over the last year, TERN has been loosely correlated with PRME. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if TERN jumps, then PRME could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TERN
1D Price
Change %
TERN100%
+1.96%
PRME - TERN
42%
Loosely correlated
-0.67%
AURA - TERN
39%
Loosely correlated
+3.20%
RLAY - TERN
39%
Loosely correlated
-0.43%
AMLX - TERN
39%
Loosely correlated
-0.76%
RXRX - TERN
38%
Loosely correlated
-4.80%
More